iShares Genomics Immunology and Healthcare ETF (IDNA)

Assets	$167.86M
Expense Ratio	0.47%
PE Ratio	14.67
Shares Out	5.40M
Dividend (ttm)	$0.31
Dividend Yield	1.03%
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Semi-Annual
Payout Ratio	15.09%

Volume	52,966
Open	30.48
Previous Close	30.27
Day's Range	29.95 - 30.48
52-Week Low	19.11
52-Week High	31.41
Beta	1.03
Holdings	64
Inception Date	Jun 11, 2019

About IDNA

Fund Home Page

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: IDNA
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Genomics and Immuno Biopharma Index

Top 10 Holdings

46.15% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	6.88%
Revolution Medicines, Inc.	RVMD	6.09%
Arcellx, Inc.	ACLX	5.00%
Ipsen S.A.	IPN	4.53%
Bayer Aktiengesellschaft	BAYN	4.17%
Takeda Pharmaceutical Company Limited	4502	4.02%
GSK plc	GSK	3.99%
Merck & Co., Inc.	MRK	3.88%
BioNTech SE	BNTX	3.87%
Twist Bioscience Corporation	TWST	3.71%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.15546	Dec 19, 2025
Jun 16, 2025	$0.15291	Jun 20, 2025
Dec 17, 2024	$0.11105	Dec 20, 2024
Jun 11, 2024	$0.11144	Jun 17, 2024
Dec 20, 2023	$0.16925	Dec 27, 2023
Jun 7, 2023	$0.07077	Jun 13, 2023

Performance

IDNA had a total return of 49.86% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.72%.